MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
12.77
-1.23
-8.79%
After Hours: 13.00 +0.23 +1.80% 19:58 05/22 EDT
OPEN
14.00
PREV CLOSE
14.00
HIGH
14.01
LOW
12.75
VOLUME
622.84K
TURNOVER
--
52 WEEK HIGH
69.97
52 WEEK LOW
11.60
MARKET CAP
203.56M
P/E (TTM)
-0.8904
1D
5D
1M
3M
1Y
5Y
1D
Tonix Pharmaceuticals posts TNX-4800 Lyme disease prevention presentation
PUBT · 5d ago
Tonix publishes TNX-1500 xenotransplantation workshop presentation
PUBT · 5d ago
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Tonix Pharma (TNXP) and Regeneron (REGN)
TipRanks · 5d ago
Weekly Report: what happened at TNXP last week (0511-0515)?
Weekly Report · 5d ago
Tonix Pharma advances TNX-4800 Lyme vaccine program
TipRanks · 05/15 13:48
Tonix publishes investor deck highlighting TONMYA fibromyalgia launch strategy
PUBT · 05/14 16:50
Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026
Barchart · 05/14 06:00
Tonix Pharmaceuticals Holding (TNXP) Q1 Loss Deepens To US$40.2 Million Reinforcing Bearish Narratives
Simply Wall St · 05/12 23:26
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.